Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor

被引:11
|
作者
Lee, David S. [1 ]
O'Keefe, Rachel A. [2 ]
Ha, Patrick K. [2 ]
Grandis, Jennifer R. [2 ]
Johnson, Daniel E. [2 ]
机构
[1] Univ Calif San Francisco, Sch Med, San Francisco, CA 94115 USA
[2] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94115 USA
来源
基金
美国国家卫生研究院;
关键词
STAT3 as a drug target; cyclic STAT3 decoy; oligodeoxynucleotide inhibitor; head and neck cancer; VEIN GRAFT FAILURE; SIGNAL TRANSDUCER; CANCER-THERAPY; IN-VIVO; MALIGNANT-TRANSFORMATION; NUCLEIC-ACIDS; TUMOR-GROWTH; CELL-GROWTH; PREVENT IV; KAPPA-B;
D O I
10.3390/ijms19061608
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclic STAT3 decoy (CS3D) is a second-generation, double-stranded oligodeoxynucleotide (ODN) that mimics a genomic response element for signal transducer and activator of transcription 3 (STAT3), an oncogenic transcription factor. CS3D competitively inhibits STAT3 binding to target gene promoters, resulting in decreased expression of proteins that promote cellular proliferation and survival. Previous studies have demonstrated antitumor activity of CS3D in preclinical models of solid tumors. However, prior to entering human clinical trials, the efficiency of generating the CS3D molecule and its stability in biological fluids should be determined. CS3D is synthesized as a single-stranded ODN and must have its free ends ligated to generate the final cyclic form. In this study, we report a ligation efficiency of nearly 95 percent. The ligated CS3D demonstrated a half-life of 7.9 h in human serum, indicating adequate stability for intravenous delivery. These results provide requisite biochemical characterization of CS3D that will inform upcoming clinical trials.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
    Xulong Zhang
    Jian Zhang
    Lihua Wang
    Haiming Wei
    Zhigang Tian
    [J]. BMC Cancer, 7
  • [2] Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
    Zhang, Xulong
    Jian, Zhang
    Wang, Lihua
    Wei, Haiming
    Tian, Zhigang
    [J]. BMC CANCER, 2007, 7 (1)
  • [3] Transcription factor Stat3 as an oncogene
    Wang, FY
    Chang, ZJ
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2002, 29 (03) : 348 - 351
  • [4] Inhibitory Effects of STAT3 Transcription Factor by Synthetic Decoy ODNs on Autophagy in Renal Fibrosis
    Kim, Young-Ah
    Kim, Hyun-Ju
    Gwon, Mi-Gyeong
    Gu, Hyemin
    An, Hyun-Jin
    Bae, Seongjae
    Leem, Jaechan
    Jung, Hyun Jin
    Park, Kwan-Kyu
    [J]. BIOMEDICINES, 2021, 9 (04)
  • [5] Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells
    Don-Doncow, Nicholas
    Escobar, Zilma
    Johansson, Martin
    Kjellstrom, Sven
    Garcia, Victor
    Munoz, Eduardo
    Sterner, Olov
    Bjartell, Anders
    Hellsten, Rebecka
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (23) : 15969 - 15978
  • [6] STAT3 beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription
    Caldenhoven, E
    vanDijk, TB
    Solari, R
    Armstrong, J
    Raaijmakers, JAM
    Lammers, JWJ
    Koenderman, L
    deGroot, RP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) : 13221 - 13227
  • [7] A novel STAT3 decoy inhibitor prevents lung cancer development
    Njatcha, Christian
    Wang, Jiayi
    Li, Huiyu
    Farooqui, Mariya
    Siegfried, Jill M.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [8] Cellular dynamics of the STAT3 transcription factor
    Cimica, Velasco
    Iyer, Janaki
    Reich, Nancy C.
    [J]. CYTOKINE, 2009, 48 (1-2) : 127 - 127
  • [9] A new role for the STAT3 inhibitor, PIAS3 - A repressor of microphthalmia transcription factor
    Levy, C
    Nechushtan, H
    Razin, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) : 1962 - 1966
  • [10] Blockage of STAT3 Signaling Pathway with a Decoy Oligodeoxynucleotide Inhibits Growth of Human Ovarian Cancer Cells
    Liu, Ming
    Wang, Fei
    Wen, Zeqing
    Shi, Min
    Zhang, Hui
    [J]. CANCER INVESTIGATION, 2014, 32 (01) : 8 - 12